Evidence map›Paper›PMID 37964449›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2024

Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing.

Po-Hong Liu, Rasmi G Nair, Celette Sugg Skinner, Caitlin C Murphy, Eric J Kim, Cynthia Ortiz, Lei Wang, Ellen Hu, Jacquelyn M Lykken, Theodore R Levin and 4 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Po-Hong Liu *Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-6205-3704
Rasmi G Nair *Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-5269-6092
Celette Sugg SkinnerPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-2535-4476
Caitlin C MurphySchool of Public Health, University of Texas Health Science Center at Houston, Houston, Texas.ORCID 0000-0001-9365-0691
Eric J KimPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-8184-2215
Cynthia OrtizPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0009-0002-1606-6170
Lei WangPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0009-0004-4778-6749
Ellen HuPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0009-0006-4287-2132
Jacquelyn M LykkenPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0003-0872-0873
Theodore R LevinDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0002-0842-2377
Beverly B GreenDepartment of Health System Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.ORCID 0000-0003-3040-3436
Erin E HahnDepartment of Health System Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.ORCID 0000-0002-8419-2331
Noel SantiniDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-6517-834X
Ethan A HalmDepartment of Medicine, Robert Wood Johnson Medical School, New Brunswick New Jersey.ORCID 0000-0003-3042-2741

Funding

Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)UM1CA222035 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA, CORLEY, DOUGLAS ALLEN · 2018 to 2023
$15.6M
Parkland-UT Southwestern PROSPR Center Colon Cancer Screening in a Safety netU54CA163308 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HALM, ETHAN A, SKINNER, CELETTE SUGG · 2011 to 2017
$8.0M
UT GASTROENTEROLOGY/HEPATOLOGY RESEARCH TRAINING PROGRAMT32DK007745 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Rodney E Infante · 1997 to 2026
$6.8M
NCI NIH HHS U54 CA163308NCI NIH HHS UM1 CA222035NIDDK NIH HHS T32 DK007745
6 · The paper itself

Abstract

backgroundFecal immunochemical test (FIT) is an effective colorectal cancer screening modality. Little is known about prevalence, reasons, and testing after unsatisfactory FIT, or a FIT that cannot be processed by the laboratory due to inadequate stool specimen or incomplete labeling.

methodsOur retrospective cohort study examined unsatisfactory FIT among average-risk individuals aged 50-74 years in a large, integrated, safety-net health system who completed an index FIT from 2010 to 2019. We determined prevalence of unsatisfactory FIT and categorized reasons hierarchically. We used multivariable logistic regression models to identify factors associated with: (i) unsatisfactory FIT; and (ii) subsequent testing within 15 months of the unsatisfactory FIT.

resultsOf 56,980 individuals completing an index FIT, 10.2% had an unsatisfactory FIT. Reasons included inadequate specimen (51%), incomplete labeling (27%), old specimen (13%), and broken/leaking container (8%). Unsatisfactory FIT was associated with being male [OR, 1.10; confidence interval (CI), 1.03-1.16], Black (OR, 1.46; CI, 1.33-1.61), Spanish speaking (OR, 1.12; CI, 1.01-1.24), on Medicaid (OR, 1.42; CI, 1.28-1.58), and received FIT by mail (OR, 2.66; CI, 2.35-3.01). Among those with an unsatisfactory FIT, fewer than half (41%) completed a subsequent test within 15 months (median, 4.4 months). Adults aged 50-54 years (OR, 1.16; CI, 1.01-1.39) and those who received FIT by mail (OR, 1.92; CI, 1.49-2.09) were more likely to complete a subsequent test.

conclusionsOne in ten returned a FIT that could not be processed, mostly due to patient-related reasons. Fewer than half completed a subsequent test after unsatisfactory FIT. IMPACT: Screening programs should address these breakdowns such as specimen collection and labeling to improve real-world effectiveness. See related In the Spotlight, p. 183.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerColonoscopyFemaleHumansMaleMass ScreeningMedicaidOccult BloodPrevalenceRetrospective Studies

Identifiers

PMID37964449
PMCPMC10873102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.